Article in Journal of molecular and cellular cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Dmitry TerentyevDepartment of Physiology and Cell Biology, Davis Heart and Lung Research Institute, Wexner Medical Center, The Ohio State University, Columbus, OH, United States of America. Electronic address: dmitry.terentyev@osumc.edu.
Andriy E BelevychDepartment of Physiology and Cell Biology, Davis Heart and Lung Research Institute, Wexner Medical Center, The Ohio State University, Columbus, OH, United States of America.
Bum-Rak ChoiCardiovascular Research Center, Cardiovascular Institute, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, RI, United States of America.
Shanna HamiltonDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, United States of America.
Funding
The mechanisms and roles of mitochondria dysfunction in cardiac arrhythmogenesisR01HL166604 · NHLBI · OHIO STATE UNIVERSITY · PI Dmitry A Terentyev · 2023 to 2026
$2.8M
Novel Mechanisms of Regulation of SK channels: Implications for Cardiac ArrhythmiaR01HL142588 · NHLBI · OHIO STATE UNIVERSITY · PI TERENTYEV, DMITRY A · 2019 to 2022
$2.4M
Cardiac ryanodine receptor and oxidative stressR00HL155492 · NHLBI · UNIVERSITY OF ARIZONA · PI HAMILTON, SHANNA · 2023 to 2025
$747k
Cardiac ryanodine receptor and oxidative stressK99HL155492 · NHLBI · OHIO STATE UNIVERSITY · PI HAMILTON, SHANNA · 2021 to 2022
$271k
Defining the role of KCNN1 in atrial arrhythmiasR03TR004471 · NCATS · OHIO STATE UNIVERSITY · PI TERENTYEV, DMITRY A · 2023 to 2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
To block or not to block: Targeting SK channels in diseased hearts. · full record | OpenQuestion